Related references
Note: Only part of the references are listed.Somatic Mutations Enriched in Cis-Regulatory Elements Affect Genes Involved in Embryonic Development and Immune System Response in Neuroblastoma
Vito Alessandro Lasorsa et al.
CANCER RESEARCH (2022)
Prognostic and immune infiltration signatures of proteasome 26S subunit, non-ATPase (PSMD) family genes in breast cancer patients
Do Thi Minh Xuan et al.
Aging-US (2021)
Single-cell RNA sequencing in cancer research
Yijie Zhang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
Single-cell transcriptional changes associated with drug tolerance and response to combination therapies in cancer
Alexandre F. Aissa et al.
NATURE COMMUNICATIONS (2021)
Metallothionein-3 promotes cisplatin chemoresistance remodelling in neuroblastoma
Miguel Angel Merlos Rodrigo et al.
SCIENTIFIC REPORTS (2021)
Tumor Heterogeneity: A Great Barrier in the Age of Cancer Immunotherapy
Nader El-Sayes et al.
CANCERS (2021)
Single-cell transcriptomics of human embryos identifies multiple sympathoblast lineages with potential implications for neuroblastoma origin
Polina Kameneva et al.
NATURE GENETICS (2021)
Single-cell transcriptomic analyses provide insights into the developmental origins of neuroblastoma
Selina Jansky et al.
NATURE GENETICS (2021)
Clinically-Relevant ABC Transporter for Anti-Cancer Drug Resistance
Huan Xiao et al.
FRONTIERS IN PHARMACOLOGY (2021)
Plasticity in Neuroblastoma Cell Identity Defines a Noradrenergic-to-Mesenchymal Transition (NMT)
Margot Gautier et al.
CANCERS (2021)
Transcription Factors Involved in Tumorigenesis Are Over-Represented in Mutated Active DNA-Binding Sites in Neuroblastoma
Mario Capasso et al.
CANCER RESEARCH (2020)
Genetic predisposition and chromosome instability in neuroblastoma
Gian Paolo Tonini et al.
CANCER AND METASTASIS REVIEWS (2020)
Association of PARP1 polymorphisms with response to chemotherapy in patients with high-risk neuroblastoma
Marianna Avitabile et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
19p loss is significantly enriched in older age neuroblastoma patients and correlates with poor prognosis
Vito Alessandro Lasorsain et al.
NPJ GENOMIC MEDICINE (2020)
Proteasome Subunits Differentially Control Myeloma Cell Viability and Proteasome Inhibitor Sensitivity
Chang-Xin Shi et al.
MOLECULAR CANCER RESEARCH (2020)
Single-Cell Transcriptome Analysis of Colon Cancer Cell Response to 5-Fluorouracil-Induced DNA Damage
Sung Rye Park et al.
CELL REPORTS (2020)
Pan-cancer single-cell RNA-seq identifies recurring programs of cellular heterogeneity
Gabriela S. Kinker et al.
NATURE GENETICS (2020)
Epitranscriptomics and epiproteomics in cancer drug resistance: therapeutic implications
Huibin Song et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Single-cell RNA-seq reveals the immune escape and drug resistance mechanisms of mantle cell lymphoma
Liang Wang et al.
CANCER BIOLOGY & MEDICINE (2020)
Functional characterization of full-length BARD1 strengthens its role as a tumor suppressor in neuroblastoma
Flora Cimmino et al.
JOURNAL OF CANCER (2020)
Single-cell analyses reveal increased intratumoral heterogeneity after the onset of therapy resistance in small-cell lung cancer
C. Allison Stewart et al.
NATURE CANCER (2020)
Chemotherapy Resistance Explained through Endoplasmic Reticulum Stress-Dependent Signaling
Entaz Bahar et al.
CANCERS (2019)
Transcriptomic Landscape of Cisplatin-Resistant Neuroblastoma Cells
Miguel Angel Merlos Rodrigo et al.
CELLS (2019)
Determining cell type abundance and expression from bulk tissues with digital cytometry
Aaron M. Newman et al.
NATURE BIOTECHNOLOGY (2019)
Comprehensive Integration of Single-Cell Data
Tim Stuart et al.
CELL (2019)
Single-Cell RNA Sequencing in Cancer: Lessons Learned and Emerging Challenges
Mario L. Suva et al.
MOLECULAR CELL (2019)
Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression
Christoph Hafemeister et al.
GENOME BIOLOGY (2019)
Chemoresistance Evolution in Triple-Negative Breast Cancer Delineated by Single-Cell Sequencing
Charissa Kim et al.
CELL (2018)
Somatic mutations in specific and connected subpathways are associated with short neuroblastoma patients' survival and indicate proteins targetable at onset of disease
Maria Rosaria Esposito et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Genomic Amplifications and Distal 6q Loss: Novel Markers for Poor Survival in High-risk Neuroblastoma Patients
Pauline Depuydt et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Genomic Amplifications and Distal 6q Loss: Novel Markers for Poor Survival in High-risk Neuroblastoma Patients
Pauline Depuydt et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
ARNT/HIF-1β links high-risk 1q21 gain and microenvironmental hypoxia to drug resistance and poor prognosis in multiple myeloma
Chuan Wu et al.
CANCER MEDICINE (2018)
Etoposide-resistance in a neuroblastoma model cell line is associated with 13q14.3 monoallelic deletion and miRNA-15a/16-1 down-regulation
Barbara Marengo et al.
SCIENTIFIC REPORTS (2018)
The role of p53 in cancer drug resistance and targeted chemotherapy
Karin Hientz et al.
ONCOTARGET (2017)
CRISPR Genome-Wide Screening Identifies Dependence on the Proteasome Subunit PSMC6 for Bortezomib Sensitivity in Multiple Myeloma
Chang-Xin Shi et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Neuroblastoma is composed of two super-enhancer-associated differentiation states
Tim van Groningen et al.
NATURE GENETICS (2017)
Heterogeneity of neuroblastoma cell identity defined by transcriptional circuitries
Valentina Boeva et al.
NATURE GENETICS (2017)
A subset of platinum-containing chemotherapeutic agents kills cells by inducing ribosome biogenesis stress
Peter M. Bruno et al.
NATURE MEDICINE (2017)
Massively parallel digital transcriptional profiling of single cells
Grace X. Y. Zheng et al.
NATURE COMMUNICATIONS (2017)
An 18 gene expression-based score classifier predicts the clinical outcome in stage 4 neuroblastoma
Daniela Formicola et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2016)
Single-cell RNA-seq supports a developmental hierarchy in human oligodendroglioma
Itay Tirosh et al.
NATURE (2016)
Exome and deep sequencing of clinically aggressive neuroblastoma reveal somatic mutations that affect key pathways involved in cancer progression
Vito Alessandro Lasorsa et al.
ONCOTARGET (2016)
Telomerase activation by genomic rearrangements in high-risk neuroblastoma
Martin Peifer et al.
NATURE (2015)
Comparison of RNA-seq and microarray-based models for clinical endpoint prediction
Wenqian Zhang et al.
GENOME BIOLOGY (2015)
Acquired differential regulation of caspase-8 in cisplatin-resistant non-small-cell lung cancer
I. Paul et al.
CELL DEATH & DISEASE (2012)
Secondary mutations of BRCA1/2 and drug resistance
Kiranjit K. Dhillon et al.
CANCER SCIENCE (2011)
Chemotherapeutic Drugs Inhibit Ribosome Biogenesis at Various Levels
Kaspar Burger et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Medical Progress: Recent Advances in Neuroblastoma.
John M. Maris
NEW ENGLAND JOURNAL OF MEDICINE (2010)
The histone H1 family: specific members, specific functions?
Annalisa Izzo et al.
BIOLOGICAL CHEMISTRY (2008)
Alteration in copy numbers of genes as a mechanism for acquired drug resistance
K Yasui et al.
CANCER RESEARCH (2004)
Share Paper
